Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1246205

NCCC[C@H](N)C(=O)N[C@H](CCc1ccccc1)C(=O)Nc1cnc2ccccc2n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.40
RHOA P61586 1/20 0.38
LNPEP Q9UIQ6 4/20 0.38
ERAP2 Q6P179 3/20 0.38
ERAP1 Q9NZ08 3/20 0.38
LTA4H P09960 1/20 0.38
MMP1 P03956 2/20 0.37
MMP3 P08254 2/20 0.37
MMP9 P14780 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
MAPK1 P28482 1/20 0.37
CCR1 P32246 2/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
S1PR1 P21453 1/20 0.36
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1246347 0.95 MMP2 (0.42) MMP2RHOALNPEPERAP2ERAP1
Trifluoroacetic Acid SCHEMBL1246150 0.85 MMP2 (0.40) MMP2LNPEPERAP2ERAP1LTA4H
Trifluoroacetic Acid SCHEMBL1245992 0.81 HDAC1 (0.46)
SCHEMBL1244303 0.80 HDAC1 (0.49) LTA4HMMP3KDM4ENPC1RAB9A
SCHEMBL1246051 0.80 HDAC1 (0.49) LTA4HMMP3KDM4ENPC1RAB9A
SCHEMBL1245469 0.80 HDAC1 (0.49) LTA4HMMP3KDM4ENPC1RAB9A
SCHEMBL1246389 0.80 HDAC1 (0.49) LTA4HMMP3KDM4ENPC1RAB9A
SCHEMBL4952247 0.80 KDM4E (0.51) RHOALNPEPERAP2LTA4HKDM4E
SCHEMBL1246107 0.79 LNPEP (0.42) MMP2LNPEPERAP2ERAP1LTA4H
SCHEMBL1245377 0.78 HDAC1 (0.40) MMP2LNPEPERAP2ERAP1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893020-B2 can be coadministered with antimicrobial agents for treatment of infections caused by drug resistant bacteria; 2-Amino-N-{4-Amino-1-[-3-phenyl-1-(R)-(quinolin-3-ylcarbomoyl)-propylcarbamoyl]-butyl}succinamic acid; 2,5-Diamino-pentanoic acid [3-phenyl-1-(R)-(4-phenyl-thiazol-2-ylcarbamoyl)-propyl]-amide MPEX PHARMACEUTICALS, INC. (US) 2011-02-22 US disclosed
US-7879795-B2 can be coadministered with antimicrobial agents for treatment of infections caused by drug resistant bacteria; 2-Amino-N-{4-Amino-1-[-3-phenyl-1-(R)-(quinolin-3-ylcarbomoyl)-propylcarbamoyl]-butyl}succinamic acid; 2,5-Diamino-pentanoic acid [3-phenyl-1-(R)-(4-phenyl-thiazol-2-ylcarbamoyl)-propyl]-amide MPEX PHARMACEUTICALS, INC. (US) 2011-02-01 US disclosed